Your browser doesn't support javascript.
loading
Risk Factors of Acute Ischemic Stroke and Mortality Among Adults With Endocardial Fibroelastosis.
Warsi, Talal; Ramphul, Kamleshun; Dulay, Mansimran Singh; Jeelani, Saddam; Verma, Renuka; Kumar, Nomesh; Dhaliwal, Jasninder Singh; Carver, Caleb; Sakthivel, Hemamalini; Gardezi, Syed Khurram Mushtaq; Deshpande, Saurabh; Sherif, Akil A; Liu, Alexander; Ahmed, Raheel.
Afiliación
  • Warsi T; University Hospitals Plymouth, UK.
  • Ramphul K; Independent Researcher, Triolet, Mauritius.
  • Dulay MS; Royal Brompton Hospital, London, United Kingdom.
  • Jeelani S; University Hospitals Plymouth, UK.
  • Verma R; University of Nevada, Las Vegas, NV.
  • Kumar N; DMC/WSU (Sinai Grace) Hospital, Detroit, MI.
  • Dhaliwal JS; University of California, Riverside, CA.
  • Carver C; Gold Coast University Hospital, Gold Coast, Australia.
  • Sakthivel H; One Brooklyn Health System/Interfaith Medical Ctr Program, Brooklyn, NY.
  • Gardezi SKM; Sheikh Shakhbout Medical City Abu Dhabi, UAE.
  • Deshpande S; Khalifa University, Abu Dhabi, UAE.
  • Sherif AA; Sri Jayadeva Institute of Cardiovascular Science and Research, Bangalore, India.
  • Liu A; Division of Cardiovascular Diseases, St Vincent Hospital, Worcester, MA.
  • Ahmed R; Royal Brompton Hospital, London, United Kingdom.
Neurologist ; 2024 Jul 22.
Article en En | MEDLINE | ID: mdl-39034931
ABSTRACT

OBJECTIVES:

Endocardial fibroelastosis (EFE) is a rare form of restrictive cardiomyopathy associated with high morbidity and mortality. The literature is sparse on information pertaining to risk stratification. Thus, we sought to highlight the risk factors of acute ischemic stroke (AIS) and mortality in adults with EFE.

METHODS:

The National Inpatient Sample (NIS) database was queried from 2001 to 2020 using the International Classification of Diseases 9th Revision (ICD-9) and 10th Revision (ICD-10) codes for adult patients with EFE. Factors associated with AIS and mortality were identified.

RESULTS:

In all, 18495 cases of EFE fit the inclusion criteria, of which 2370 (12.82%) had AIS. The mean ages for patients with and without AIS were 62.37 and 54.24, respectively. Multivariate regression suggested greater odds of AIS in patients with hypertension (aOR 2.329, P<0.01), dyslipidemia (aOR 1.566, P<0.01), peripheral vascular disease (PVD) (aOR 1.736, P<0.01), alcohol abuse (aOR 1.817, P<0.01), age >60 y (aOR 1.646, P<0.01), females (vs. males, aOR 1.238, P<0.01), and smokers (aOR 1.697, P<0.01). Patients with cirrhosis (aOR 0.174, P<0.01), CKD (aOR 0.369, P<0.01), COPD (aOR 0.402, P<0.01), atrial fibrillation (aOR 0.542, P<0.01) had lower odds of AIS. 3.1% of EFE patients with AIS died. Diabetes (aOR 11.665, P<0.01) and COPD (aOR 3.201, P=0.017) were associated with the greatest odds of all-cause mortality. Dyslipidemia (aOR 0.387, P=0.010) and females (vs. males, aOR 0.432, P=0.012) had reduced odds of all-cause mortality.

CONCLUSION:

Several risk factors are associated with AIS in EFE, while diabetes, COPD, and being male are associated with mortality in EFE.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurologist Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurologist Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido